Differences in Time-in-Range, Glycemic Variability, and the Glucose Management Indicator in Pregnant Women with Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes
In this medfyle
Expert commentary by Denice Feig, MD, MSc, FRCPC
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ADA 2020 - 80th Scientific Sessions and presented by:
Sarit Polsky, MD
University of Colorado Denver, Barbara Davis Center for Childhood Diabetes, Denver, CO, USA
The content is produced by Infomedica, the official reporting partner of ADA 2020 Virtual Meeting. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Dana M. Dabelea, MD, PhD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Denice Feig, MD, MSc, FRCPC
Professor of Medicine, Obstetrics & Gynecology, and Health Policy, Management & Evaluation, University of Toronto
Clinician Scientist, Lunenfeld-Tanenbaum Research Institute,
Head, Diabetes & Endocrinology in Pregnancy Program
About the Expert
Denice Feig, MD, MSc, FRCPC
Professor of Medicine, Obstetrics & Gynecology, and Health Policy, Management & Evaluation, University of Toronto
Clinician Scientist, Lunenfeld-Tanenbaum Research Institute,
Head, Diabetes & Endocrinology in Pregnancy Program
Dr. Feig is head of the Diabetes in Pregnancy Program at Mount Sinai Hospital and University Health Network. She is professor at University of Toronto in the Department of Medicine, and has a Master's degree in clinical epidemiology. She is cross-appointed to both the Department of Obstetrics and Gynaecology and the Institute of Health Policy, Management and Evaluation. She is currently the chair of the American Diabetes Association Pregnancy Planning Committee, the past chair of the Canadian Diabetes in Pregnancy Study Group, the current chair of the University of Toronto/BBDC Diabetes in Pregnancy Study Group, and sits on the International Diabetes in Pregnancy Study Group. She participated in the recent CDA Clinical Practice Guidelines in the area of pregnancy. She has numerous grants and publications in the area of diabetes and pregnancy.
